Lazard Asset Management
ASTH icon

Lazard Asset Management’s Astrana Health ASTH Stock Holding History

Lazard Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-74,285
Closed -$1.84M – 2108
2025
Q4 		$1.84M Buy
+74,285
New +$1.97M ﹤0.01% 906
2023
Q2 		– Sell
-267
Closed -$9K – 2586
2023
Q1 		$9K Sell
267
-3,173
-92% -$111K ﹤0.01% 2137
2022
Q4 		$101K Hold
3,440
– – ﹤0.01% 1533
2022
Q3 		$134K Hold
3,440
– – ﹤0.01% 1361
2022
Q2 		$132K Buy
3,440
+2,064
+150% +$78.5K ﹤0.01% 1402
2022
Q1 		$66K Buy
+1,376
New +$71K ﹤0.01% 1608
2021
Q1 		– Sell
-3,244
Closed -$59K – 2059
2020
Q4 		$59K Buy
3,244
+2,802
+634% +$50.4K ﹤0.01% 1333
2020
Q3 		$7K Buy
+442
New +$7.63K ﹤0.01% 1523

Other funds holding ASTH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return